PWPS
KRYS icon

Pinnacle Wealth Planning Services’s Krystal Biotech KRYS Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Buy
814
+20
+3% +$5.98K 0.03% 370
2026
Q1 		$205K Buy
794
+35
+5% +$9.31K 0.02% 472
2025
Q4 		$187K Buy
+759
New +$160K 0.02% 488

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pinnacle Wealth Planning Services's KRYS Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its Krystal Biotech (KRYS) stake by 2.5% in Q2 2026, buying an estimated $5.98K and bringing the position to 814 shares worth $303K. The position accounts for 0.03% of the portfolio, ranked #370.

Pinnacle Wealth Planning Services first reported a position in KRYS in Q4 2025 and has held it in 3 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Pinnacle Wealth Planning Services held 814 shares of Krystal Biotech worth $303K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 20 Krystal Biotech shares in Q2 2026, an estimated $5.98K.
  • Krystal Biotech made up 0.03% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #370 holding.
  • Pinnacle Wealth Planning Services first reported a position in Krystal Biotech in Q4 2025 and has held it in 3 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.